Research Library

Peer-reviewed studies and published research on every compound we carry. Linked directly to PubMed for full-text access.

Published Studies

Compounds Covered

100%

Peer-Reviewed

BPC-157Recovery2021

Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease

Sikiric P, et al. · Curr Pharm Des

Comprehensive review of BPC-157's effects on inflammatory bowel disease models, demonstrating cytoprotective and healing properties across multiple preclinical studies.

PubMed DOI

BPC-157Recovery2022

BPC 157 and its role in accelerating wound healing

Cerovecki T, et al. · Med Sci Monit Basic Res

Investigation of BPC-157's wound healing acceleration in research models, showing significant improvement in tissue repair mechanisms.

PubMed DOI

BPC-157Recovery2022

Pentadecapeptide BPC 157 and the central nervous system

Sikiric P, et al. · Neural Regen Res

Review of BPC-157's neuroprotective properties and effects on central nervous system pathways in preclinical research models.

PubMed DOI

SemaglutideWeight Management2021

Once-weekly semaglutide in adults with overweight or obesity

Wilding JPH, et al. · N Engl J Med

STEP 1 trial demonstrating significant weight reduction with once-weekly semaglutide 2.4mg in adults with overweight or obesity.

PubMed DOI

SemaglutideWeight Management2016

Semaglutide and cardiovascular outcomes in patients with type 2 diabetes

Marso SP, et al. · N Engl J Med

SUSTAIN-6 trial showing cardiovascular safety and potential benefits of semaglutide in type 2 diabetes patients.

PubMed DOI

RetatrutideWeight Management2023

Triple-hormone-receptor agonist retatrutide for obesity

Jastreboff AM, et al. · N Engl J Med

Phase 2 trial of the triple GLP-1/GIP/glucagon receptor agonist retatrutide showing unprecedented weight reduction in participants with obesity.

PubMed DOI

TirzepatideWeight Management2022

Tirzepatide once weekly for the treatment of obesity

Jastreboff AM, et al. · N Engl J Med

SURMOUNT-1 trial demonstrating tirzepatide's efficacy for weight management with dual GIP/GLP-1 receptor agonism.

PubMed DOI

TB-500Recovery2007

Thymosin beta 4 promotes angiogenesis, wound healing, and hair growth

Philp D, et al. · Ann N Y Acad Sci

Research demonstrating thymosin beta 4's role in promoting angiogenesis and accelerating wound healing through cell migration.

PubMed DOI

TB-500Recovery2023

Thymosin beta4 is an endogenous iron chelator and molecular switch of ferroptosis

Han X, et al. · Theranostics

Novel finding that thymosin beta-4 functions as an endogenous iron chelator with implications for ferroptosis regulation.

PubMed DOI

GHK-CuAnti-Aging2015

GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration

Pickart L, et al. · Biomed Res Int

Comprehensive review of GHK-Cu's effects on collagen synthesis, glycosaminoglycan production, and stem cell activity in skin regeneration.

PubMed DOI

GHK-CuAnti-Aging2012

The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions

Pickart L, et al. · Oxid Med Cell Longev

Review of GHK-Cu's antioxidant properties and its role in preventing oxidative stress and age-related degenerative conditions.

PubMed DOI

CJC-1295Growth & Recovery2006

Prolonged stimulation of growth hormone secretion after continuous infusion of GRF(1-29)NH2

Alba M, et al. · J Clin Endocrinol Metab

Study on modified GRF analog CJC-1295 demonstrating sustained growth hormone release with favorable pharmacokinetics.

PubMed DOI

SelankCognitive2023

Selank and its metabolites maintain BDNF expression in basal and fear extinction conditions

Inozemtsev AN, et al. · Peptides

Research on Selank's effects on BDNF expression, demonstrating nootropic properties through neurotrophic factor modulation.

PubMed DOI

NAD+Anti-Aging2021

NAD+ metabolism and its roles in cellular processes during ageing

Covarrubias AJ, et al. · Nat Rev Mol Cell Biol

Comprehensive review of NAD+ metabolism in cellular aging, covering sirtuin activation, DNA repair, and mitochondrial function.

PubMed DOI

NAD+Anti-Aging2018

Therapeutic potential of NAD-boosting molecules

Rajman L, et al. · Cell Metab

Review of NAD+ precursors and their therapeutic potential for age-related diseases, metabolic disorders, and neurodegeneration.

PubMed DOI

PT-141Research2020

Bremelanotide: new drug approved for treating hypoactive sexual desire disorder

Clayton AH, et al. · Ann Pharmacother

Review of bremelanotide (PT-141) as a melanocortin receptor agonist studied for its effects on sexual function through central nervous system pathways.

PubMed DOI

Can't find what you're looking for?

Our research library is continuously updated. Contact us if you need specific studies or CoA documentation for any compound.

contact@novatidepeptide.com